ClinicalTrials.Veeva

Menu

Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II

Mass General Brigham logo

Mass General Brigham

Status

Enrolling

Conditions

Depression
Anxiety Disorders

Treatments

Behavioral: IntelliCare Plus

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05555875
2022P001673
K23MH120324 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.

Full description

This 8-week, clinical trial involves primary care patients with clinically significant depression and/or anxiety recruited via provider referral. Participants will received access to a digital mental health intervention with known efficacy and be randomized to an engagement strategy condition--a previously-validated Coach Support protocol (CS), a newly-developed automated motivational messaging protocol (AMM), both or neither. To further understand how messages in the AMM arms function, message delivery will be micro-randomized: each day participants will be randomized to receive a message or not, such that they receive an average of 4.2 messages/week. Micro-randomization allows causal inference about the near-term impact of message delivery (i.e., are AMMs a cue to action) and the relationship between message impact and context (e.g., day in study). Measured outcome data will include level of engagement (operationalized as minutes of intervention use) and weekly self-reports of clinical outcomes.

Enrollment

76 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mass General Brigham primary care patient
  • Age 18-75
  • Clinically significant symptoms of depression (Patient Health Questionnaire-9 (PHQ-9) greater than or equal to 10) and/or anxiety (Generalized Anxiety Disorder-7 (GAD-7) greater than or equal to 8)
  • Owns a smartphone capable of running the study applications
  • Fluent in English.

Exclusion criteria

  • Diagnosis of bipolar I or bipolar II disorder per patient report or the patient's medical record
  • Diagnosis of any psychotic disorder per patient report or the patient's medical record
  • Current substance use disorder per patient report or the patient's medical record
  • Acute and/or unstable medical problem that may interfere with participation (e.g., scheduled for surgery in the next two months).

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

76 participants in 4 patient groups

IntelliCare with Automated Motivational Messaging and Coach Support
Experimental group
Description:
IntelliCare Plus mobile application intervention with two engagement strategies, automated motivational messaging and coach support.
Treatment:
Behavioral: IntelliCare Plus
IntelliCare with Automated Motivational Messaging
Experimental group
Description:
IntelliCare Plus mobile application intervention with one engagement strategy, automated motivational messaging.
Treatment:
Behavioral: IntelliCare Plus
IntelliCare with Coach Support
Experimental group
Description:
IntelliCare Plus mobile application intervention with one engagement strategy, coach support.
Treatment:
Behavioral: IntelliCare Plus
IntelliCare Alone
Active Comparator group
Description:
IntelliCare Plus mobile application intervention with no additional engagement strategy applied.
Treatment:
Behavioral: IntelliCare Plus

Trial contacts and locations

1

Loading...

Central trial contact

Jessica M Lipschitz, PhD; Katherine E Burdick, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems